Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Multi Makmur Lemindo Tbk. (PIPA) Price & Performance

UBC Medical Indonesia Tbk.Trade
Multi Makmur Lemindo Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Multi Makmur Lemindo Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp166 (market cap 651.75B, 45.1K 24h volume), while Multi Makmur Lemindo Tbk. trades at Rp126 (market cap 424.84B, 11.65M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Multi Makmur Lemindo Tbk. is more actively traded (11.65M versus 45.1K). Which is the better fit depends on your goals.

LABSPIPA
Market Cap
651.75B424.84B
Volume
45.1K11.65M
Lot
451116.47K
Turnover
7.44M1.47B
Average Price
165.07125.83
Value
7.44M1.47B
Indicative Equilibrium Price
165127
Indicative Equilibrium Volume
30033.74K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
PIPA
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Multi Makmur Lemindo Tbk.

PT Multi Makmur Lemindo Tbk (the Company) was established based on Notarial Deed No. 66 dated January 11, 2012 of Deni Nugraha, S.E., S.H., M.Kn., notary in Tangerang. The Company started its commercial operations in 2005.

Read more on PIPA